Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
15025 | 667 | 39.4 | 70% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
645 | 12871 | MAMMOGRAPHIC DENSITY//BREAST DENSITY//CANCER CAUSES & CONTROL |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MOLECULAR APOCRINE | Author keyword | 9 | 83% | 1% | 5 |
2 | DAME ROMA MITCHELL CANC S | Address | 2 | 14% | 2% | 14 |
3 | ESTROGEN RECEPTOR NEGATIVE | Author keyword | 1 | 27% | 1% | 4 |
4 | SECC INFORMAC SANITARIA | Address | 1 | 40% | 0% | 2 |
5 | MOL BIOENERGET | Address | 1 | 33% | 0% | 2 |
6 | TARGET MOL STUDY GRP | Address | 1 | 33% | 0% | 2 |
7 | ADJUVANT TAMOXIFEN TREATMENT | Author keyword | 1 | 50% | 0% | 1 |
8 | ANDROGEN RESPONSIVE | Author keyword | 1 | 50% | 0% | 1 |
9 | AR ANDROGEN RECEPTOR | Author keyword | 1 | 50% | 0% | 1 |
10 | CAN GENOM | Address | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 5 ANDROSTENE 3 BETA 17 BETA DIOL | 8 | 75% | 1% | 6 |
2 | FEMALE NOBLE RATS | 7 | 53% | 1% | 9 |
3 | URINARY ANDROGEN | 6 | 80% | 1% | 4 |
4 | FLUOXYMESTERONE | 5 | 63% | 1% | 5 |
5 | TA REPEAT POLYMORPHISM | 4 | 75% | 0% | 3 |
6 | SEX HORMONE LEVELS | 3 | 13% | 4% | 25 |
7 | ONE YEAR PERIOD | 3 | 35% | 1% | 7 |
8 | PROTEIN BOUND ESTRADIOL | 3 | 31% | 1% | 8 |
9 | C 19 DELTA 5 STEROIDS | 2 | 38% | 1% | 5 |
10 | INCREASED ANDROGENIC ACTIVITY | 2 | 67% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The intracrinology of breast cancer | 2015 | 3 | 86 | 27% |
The Androgen Receptor in Breast Tissues: Growth Inhibitor, Tumor Suppressor, Oncogene? | 2012 | 58 | 112 | 45% |
Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis | 2014 | 9 | 42 | 57% |
Endogenous estrogen and postmenopausal breast cancer a quantitative review | 1997 | 151 | 26 | 73% |
Complexities of androgen receptor signalling in breast cancer | 2014 | 4 | 181 | 61% |
Androgen receptor as a targeted therapy for breast cancer | 2012 | 25 | 68 | 47% |
Androgen receptor in triple negative breast cancer | 2013 | 22 | 133 | 37% |
Revising the role of the androgen receptor in breast cancer | 2014 | 5 | 81 | 47% |
Androgens and the breast | 2009 | 44 | 46 | 37% |
Triple-Negative Breast Cancer Role of the Androgen Receptor | 2010 | 48 | 22 | 41% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DAME ROMA MITCHELL CANC S | 2 | 14% | 2.1% | 14 |
2 | SECC INFORMAC SANITARIA | 1 | 40% | 0.3% | 2 |
3 | MOL BIOENERGET | 1 | 33% | 0.3% | 2 |
4 | TARGET MOL STUDY GRP | 1 | 33% | 0.3% | 2 |
5 | CAN GENOM | 1 | 50% | 0.1% | 1 |
6 | CENT HOSP XUZHOU ORTHOPAED SURG | 1 | 50% | 0.1% | 1 |
7 | FEDERATIF RECH 69 | 1 | 50% | 0.1% | 1 |
8 | GYNAECOL GYNAECOL ONCOL ENDOCRINOL | 1 | 50% | 0.1% | 1 |
9 | MED EDUC IL 3202 | 1 | 50% | 0.1% | 1 |
10 | REPROD HLTH TRAINING COMMUN UNIT | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000253492 | BREAST CYST FLUID//PROLACTIN INDUCIBLE PROTEIN//GROSS CYSTIC BREAST DISEASE |
2 | 0.0000202814 | STEROID SULFATASE//ESTRONE SULFATASE//AROMATASE |
3 | 0.0000143458 | CYP17//ANDROGEN RECEPTOR GENE//CAG REPEAT POLYMORPHISM |
4 | 0.0000141948 | REPRODUCTIVE FACTORS//AGE AT FIRST FULL TERM PREGNANCY//AGE AT LAST BIRTH |
5 | 0.0000121584 | DANISH NURSE COHORT//EPES EPIDEMIOL//BENIGN PROLIFERATIVE EPITHELIAL DISORDERS OF THE BREAST |
6 | 0.0000120072 | SEX DISCRIMINATION OF CANCER RISK//STEROID CARCINOGENESIS//TUMOR SUPPRESSOR GENE INACTIVATION |
7 | 0.0000109297 | SHBG GENE POLYMORPHISM//CLIN MED CHEM MED//ENDOCRINE SECT INTERNAL MED 3 |
8 | 0.0000100124 | ATLAS PROJECT//AUXIN A//AUXIN B |
9 | 0.0000094847 | ESTROGENIC RECRUITMENT//AMINOGLUTETHIMIDE//CYCLIC TREATMENT |
10 | 0.0000087390 | CORTICOSTEROID BINDING GLOBULIN//SEX STEROID BINDING PROTEIN//SEX HORMONE BINDING GLOBULIN |